Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor
A novel class of antagonists of the human glucagon receptor (hGCGR) has been discovered. An SAR exploration of the lead class resulted in 13, which exhibited good potency as an hGCGR functional antagonist (IC 50 = 34 nM) and moderate bioavailability (36% in mice). A novel class of antagonists of the...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters Vol. 15; no. 5; pp. 1401 - 1405 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford
Elsevier Ltd
01-03-2005
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A novel class of antagonists of the human glucagon receptor (hGCGR) has been discovered. An SAR exploration of the lead class resulted in
13, which exhibited good potency as an hGCGR functional antagonist (IC
50
=
34
nM) and moderate bioavailability (36% in mice).
A novel class of antagonists of the human glucagon receptor (hGCGR) has been discovered. Systematic modification of the lead compound identified substituents that were essential for activity and those that were amenable to further optimization. This SAR exploration resulted in the synthesis of
13, which exhibited good potency as an hGCGR functional antagonist (IC
50
=
34
nM) and moderate bioavailability (36% in mice). |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2005.01.003 |